No pricks: Oral TB drug for under 5 gets nod
Thursday, 11 April 2024 ()
Delamanid approval for under 5 children in India in March revolutionizes paediatric TB treatment, eliminating painful injectables. Central TB Division broadens Delamanid use for MDR-TB and XDR-TB, praised by Dr Sushant Mane and Dr Vikas Oswal.
|
||||
You Might Like💡 newsR Knowledge: Other News Mentions |
||||
